Abstract:Background: Since December 2019, the emergence of severe acute respiratory syndrome coronavirus 2, which gave rise to coronavirus disease 2019 (COVID-19), has considerably impacted global health. The identification of effective anticoronavirus peptides (ACVPs) and the establishment of robust data storage methods are critical in the fight against COVID-19. Traditional wet-lab peptide discovery approaches are time-- consuming and labor-intensive. With advancements in computer technology and bioinformatics, machine learning has gained prominence in the extraction of functional peptides from extensive datasets. Methods: In this study, we comprehensively review data resources and predictors related to ACVPs published over the past two decades. In addition, we analyze the influence of various factors on model performance. Results: We have reviewed nine ACVP-containing databases, which integrate detailed information on protein fragments effective against coronaviruses, providing crucial references for the development of antiviral drugs and vaccines. Additionally, we have assessed 15 peptide predictors for antiviral or specifically anticoronavirus activity. These predictors employ computational models to swiftly screen potential antiviral candidates, offering an efficient pathway for drug development. Conclusion: Our study provides conclusive results and insights into the performance of different computational methods, and sheds light on the future trajectory of bioinformatics tools for ACVPs. This work offers a representative overview of contributions to the field, with an emphasis on the crucial role of ACVPs in combating COVID-19.

Method and Progress of the Research on Virus Affinity Peptide

Virus-Derived Peptides for Clinical Applications

Progress in Molecular Biological Diagnosis of Human Herpesviruses

Progress on Techniques of Virus Receptors

Current Development of Data Resources and Bioinformatics Tools for Anticoronavirus Peptide

Antiviral peptides as promising therapeutic drugs

Advances in Studies on Phage Display Systems

Innovative Alignment-Based Method for Antiviral Peptide Prediction

Discovery of Antivirals Using Phage Display

Review and perspective on bioinformatics tools using machine learning and deep learning for predicting antiviral peptides

Advances in phage–host interaction prediction: in silico method enhances the development of phage therapies

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery

A two-stage computational framework for identifying antiviral peptides and their functional types based on contrastive learning and multi-feature fusion strategy

Design and Preliminary Application of Affinity Peptide Based on the Structure of the Porcine Circovirus Type II Capsid (PCV2 Cap)

Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides

Discovery and development of antiviral drugs

Aptamer-based diagnostic and therapeutic approaches for animal viruses: A review

Current Progress in Antiviral Strategies.

Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses

Broad‐Spectrum Antiviral Peptides and Polymers

Microfluidics, an effective tool for supporting phage display-A review